BBIO BridgeBio Pharma, Inc.
Price Chart
Executive Summary
Three BridgeBio insiders, including the CEO and President/CFO, sold a total of $1.24M in open-market sales over a 7-day window. While the dollar amount is modest relative to the $13.5B market cap (0.009%), the cluster includes the top two C-suite executives and is amplified by cross-filing context suggesting proximity to earnings, agreements, or offerings.
Key Financial Metrics
Actionable Insight
The cluster of C-suite insider sales, while small in absolute terms, is amplified by cross-filing context suggesting material corporate events may be pending. Monitor for upcoming earnings, partnership agreements, or equity offerings that could explain the timing. The CEO and CFO both selling in the same window is unusual and warrants close attention.
Key Facts
- Three insiders sold a total of $1.24M in open-market sales from May 14-21, 2026.
- CEO Kumar Neil sold 2,256 shares at $67.57 for $152K.
- President and CFO Thomas Trimarchi sold 10,500 shares at $64.82 for $678K.
- Director Randal W. Scott sold 6,200 shares at $66.69 for $413K.
- Total sales represent 0.009% of BridgeBio's $13.5B market cap.
- Cross-filing context shows multiple amplifier signals for this cluster, including proximity to earnings, agreements, offerings, and press events.
Financial Impact
Total insider sales of $1.24M, or 0.009% of market cap.
Risk Factors
- Insider sales may signal management's view that the stock is fully valued or that near-term catalysts are uncertain.
- Cross-filing amplifier signals suggest potential upcoming corporate events (earnings, offerings, agreements) that could introduce volatility.
- Historical calibration shows low win rates (22-32%) for similar impact scores in this segment, suggesting the market may not react strongly to this pattern.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BBIO-1779828894709 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
13d ago
|
Press Release
| $66.44 $63.88 | ▼ −3.85% | ▼ −5.06% | $67.37 (+1.40%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $66.44 $65.48 | ▲ +1.44% | ▲ +1.91% | $67.37 (−1.40%) |
|
May 21, 2026
19d ago
|
144
| $69.12 $65.36 | ▼ −5.44% | ▼ −7.10% | $67.37 (−2.53%) |
|
May 19, 2026
21d ago
|
Insider Cluster
| $68.22 $68.45 | ▲ +0.34% | ▼ −1.47% | $67.37 (−1.25%) |
|
May 12, 2026
28d ago
|
Press Release
| $65.95 $65.32 | ▼ −0.96% | ▼ −1.03% | $67.37 (+2.15%) |
|
May 11, 2026
29d ago
|
Press Release
| $64.68 $65.32 | ▲ +0.99% | ▲ +1.07% | $67.37 (+4.16%) |
|
May 8, 2026
4w ago
|
S-3ASR
| $67.39 $69.66 | ▲ +3.37% | ▲ +1.90% | $67.37 (−0.03%) |
|
May 7, 2026
4w ago
|
Press Release
| $67.39 $69.66 | ▲ +3.37% | ▲ +1.90% | $67.37 (−0.03%) |
|
May 6, 2026
4w ago
|
Press Release
| $68.09 $65.95 | ▼ −3.14% | ▼ −4.27% | $67.37 (−1.06%) |
|
May 5, 2026
5w ago
|
Press Release
| $68.78 $65.95 | ▼ −4.11% | ▼ −6.10% | $67.37 (−2.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access